Sign in to follow
Search Results

0 results for 'Gilead Sciences'

You can use to get even better search results Gilead Sciences
August 16, 2024 | Corporate Counsel

Veteran Legal Chief Who Quit 2 Years Ago—Declaring 'I Need a Break'—Returns to In-House Game

Brett Pletcher has taken the legal reins of the late-stage biopharma Cytokinetic.
3 minute read
August 12, 2024 | Law.com

How I Made General Counsel: 'Keep Betting on Yourself Against the Odds,' Says Maryam Abdul-Kareem of Arcellx

"My advice is to keep betting on yourself against the odds. Eventually, someone else will bet on you too, and you will experience more and more wins."
10 minute read
June 11, 2024 | The Recorder

Wilmer Hires Latham Partner as Co-Chair of Growing Life Sciences Practice

Life sciences represents "the biggest growth opportunity we see," said transactional department chair Mick Bain.
3 minute read
March 22, 2024 | Corporate Counsel

Kirkland & Ellis to Represent Apple in Landmark Antitrust Lawsuit

The Kirkland team includes star litigators as well as a partner who spent 13 years at the Federal Trade Commission.
3 minute read
March 20, 2024 | Delaware Business Court Insider

Superior Court: More Overlap in Case Facts Needed for Insurer to Deny D&O Coverage

Delaware Superior Court Judge Paul R. Wallace granted a California-based biotech company's motion for partial summary judgment.
3 minute read
Law Journal Press | Digital Book A Letter from Your Client Authors: By Alex Geisler View this Book

View more book results for the query "Gilead Sciences"

March 19, 2024 | National Law Journal

Wilmer's Revenue and Profits Soar Amid Boom in Countercyclical Practices

While the firm landed in the spotlight for its clients' congressional testimony, Wilmer's revenue and profit grew 10% or more in 2023, amid gains in litigation and investigations practices.
4 minute read
March 18, 2024 | The American Lawyer

Kirkland Crosses $7B Mark, With Steady And Countercyclical Business Drivers

The firm continued to improve its profit margin, as average PEP rose nearly 6% to $7.955 million, according to American Lawyer reporting.
5 minute read
March 13, 2024 | Corporate Counsel

After Honing Skills at Pharma Heavyweight, Attorney Takes First GC Post

"I love the fast pace and urgency," said Andy Rittenberg, the newly appointed general counsel of Coherus BioSciences. "We have a lot on our plates and accomplish a lot with a small team."
2 minute read
March 06, 2024 | The American Lawyer

Proskauer Sees Slight Revenue Drop, Showing 'Great Strength' With Headwinds

After client activity slowed down in 2023, chair-elect Timothy Mungovan said Proskauer is very bullish on 2024.
6 minute read
March 04, 2024 | The Recorder

How a Recent California Appellate Court Decision Will Chill Drug Development, Raise Pharmaceutical Costs

"In allowing this case to proceed, California outdid itself by threatening the core of pharmaceutical innovation in this country," according to Jeremy Kidd, law professor at Drake University Law School.
4 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Why Embracing Change Is Essential for Your Legal Department

    Brought to you by DiliTrust

    Download Now

  • International Export and Trade Assistance State Law Survey

    Brought to you by LexisNexis®

    Download Now

  • How This Personal Injury Firm Reduced Client Intake Time by 80%

    Brought to you by PracticePanther

    Download Now

  • The Hidden Cost of Bad Reviews: Why Law Firms & Attorneys Can't Afford a Damaged Online Reputation

    Brought to you by Erase.com

    Download Now